SPRINGWORKS THERAPEUTICS INC's ticker is SWTX and the CUSIP is 85205L107. A total of 153 filers reported holding SPRINGWORKS THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.10 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $149,000 | -92.0% | 5,220 | -93.1% | 0.00% | -100.0% |
| Q2 2022 | $1,865,000 | -71.1% | 75,719 | -33.7% | 0.00% | -69.2% |
| Q1 2022 | $6,445,000 | +1.2% | 114,190 | +11.1% | 0.01% | +8.3% |
| Q4 2021 | $6,369,000 | +22.2% | 102,780 | +25.1% | 0.01% | +9.1% |
| Q3 2021 | $5,212,000 | -2.2% | 82,161 | +27.1% | 0.01% | 0.0% |
| Q2 2021 | $5,327,000 | +63.8% | 64,634 | +46.1% | 0.01% | +57.1% |
| Q1 2021 | $3,253,000 | +72.4% | 44,226 | +69.9% | 0.01% | +75.0% |
| Q4 2020 | $1,887,000 | +52.1% | 26,026 | 0.0% | 0.00% | +33.3% |
| Q3 2020 | $1,241,000 | +214.2% | 26,026 | +176.8% | 0.00% | +200.0% |
| Q2 2020 | $395,000 | +55.5% | 9,403 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $254,000 | – | 9,403 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 5,831,307 | $480,558,000 | 31.49% |
| Consonance Capital Management LP | 1,199,339 | $98,838,000 | 11.90% |
| Boxer Capital, LLC | 2,075,905 | $171,075,000 | 6.04% |
| Perceptive Advisors | 9,699,824 | $799,362,000 | 5.19% |
| Orbimed Advisors | 6,044,266 | $498,108,000 | 5.04% |
| Samsara BioCapital, LLC | 169,852 | $13,998,000 | 1.73% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 1,375,775 | $113,378,000 | 1.50% |
| SPHERA FUNDS MANAGEMENT LTD. | 195,117 | $16,080,000 | 1.09% |
| Artal Group S.A. | 500,000 | $41,205,000 | 0.84% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 558,574 | $46,032,000 | 0.82% |